There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific ...

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific community: the need to phase out animal testing in biomedical research. The new ...

Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...

With the continued use of COVID-19 vaccines worldwide, there’s a massive amount of data that shows mRNA shots are safe.

The Global Sepsis Diagnostics Market valued at ~$510 million (2021) is set to witness a healthy growth rate of 9% in the next 5 years. Development of rapid diagnostic tests/point-of-care techniques, ...

Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results.

Biontech SE and Bristol Myers Squibb Co. are teaming up to develop Biontech’s bispecific antibody targeting PD-L1 and VEGF-A, BNT-327, in a deal possibly worth over $11 billion. The companies will ...

The US Government’s Biomedical Advanced Research and Development Authority (BARDA) has made an initial investment of approximately $55 million for rapid development of VIR-2482, the Vir ...

Life science companies developing bird flu vaccines and antivirals are gaining attention as the avian influenza subtype H5N1 ...

The payment is part of an $85 million award from the Biomedical Advanced Research and Development Authority (BARDA) to accelerate the development of LBP-EC01, which has already shown promise in ...